---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-23-010856"
form_type: "8-K"
ticker: "VTAK"
cik: "0001716621"
company_name: "Catheter Precision, Inc."
filed_at: "2023-08-15T23:59:59+00:00"
generated_at: "2026-06-11T09:29:56.889409+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Ra Medical Systems estimates Q2 2023 revenue of $96,000; H1 2023 revenue $181,000

## Summary
- Preliminary Q2 2023 revenue estimate of approximately $96,000 (versus $0 prior year quarter, if applicable).
- Six-month revenue estimate of approximately $181,000 for H1 2023.
- Revenue figures are preliminary and subject to adjustment upon completion of the audit review.
- Company filed a Form 12b-25 (NT 10-Q) indicating a delay in its quarterly report.

## SEC filing metadata
- accession: 0001654954-23-010856
- form_type: 8-K
- ticker: VTAK
- cik: 0001716621
- company_name: Catheter Precision, Inc.
- filed_at: 2023-08-15T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1716621/000165495423010856/0001654954-23-010856-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1716621/000165495423010856/rmed_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-23-010856
- JSON: https://secwatch.observer/filing/0001654954-23-010856.json
- Plain text: https://secwatch.observer/filing/0001654954-23-010856.txt

## Key facts
- Earnings Releases
  Catheter Precision, Inc. reported the six months ended June 30, 2023 results: revenue approximately $181,000.
  - Period: the six months ended June 30, 2023
  - Revenue: approximately $181,000
  - Result: preliminary results
  source text: On August 15, 2023, Ra Medical Systems, Inc. (the “Company”) filed a Form 12b-25 with the Securities and Exchange Commission that estimated that the Company will recognize revenues of approximately $96,000 for the quarter ended June 30, 2023 and approximately $181,000 for the six months ended June 30, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1716621/000165495423010856/0001654954-23-010856-index.htm
- Earnings Releases
  Catheter Precision, Inc. reported the quarter ended June 30, 2023 results: revenue approximately $96,000.
  - Period: the quarter ended June 30, 2023
  - Revenue: approximately $96,000
  - Result: preliminary results
  source text: On August 15, 2023, Ra Medical Systems, Inc. (the “Company”) filed a Form 12b-25 with the Securities and Exchange Commission that estimated that the Company will recognize revenues of approximately $96,000 for the quarter ended June 30, 2023 and approximately $181,000 for the six months ended June 30, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1716621/000165495423010856/0001654954-23-010856-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.